Imaging of Fibrosis in Chronic Pancreatitis

Chronic pancreatitis (CP) describes long-standing inflammation of the pancreas, which leads to irreversible and progressive inflammation of the pancreas with fibrosis. CP also leads to abdominal pain, malnutrition, and permanent impairment of exocrine/endocrine functions. However, it is difficult to...

Full description

Bibliographic Details
Main Authors: Yasunobu Yamashita, Reiko Ashida, Masayuki Kitano
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.800516/full
_version_ 1798034294826860544
author Yasunobu Yamashita
Reiko Ashida
Masayuki Kitano
author_facet Yasunobu Yamashita
Reiko Ashida
Masayuki Kitano
author_sort Yasunobu Yamashita
collection DOAJ
description Chronic pancreatitis (CP) describes long-standing inflammation of the pancreas, which leads to irreversible and progressive inflammation of the pancreas with fibrosis. CP also leads to abdominal pain, malnutrition, and permanent impairment of exocrine/endocrine functions. However, it is difficult to assess CP pathologically, and imaging modalities therefore play an important role in the diagnosis and assessment of CP. There are four modalities typically used to assess CP. Pancreatic duct features are assessed with magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP). However, ERCP is a rather invasive diagnostic modality for CP, and can result in adverse events such as post-ERCP pancreatitis. Computed tomography (CT) is often the most appropriate initial imaging modality for patients with suspected CP, and has high diagnostic specificity. However, CT findings typically only appear in advanced stages of CP, and it is difficult to detect early CP. Endoscopic ultrasonography (EUS) provides superior spatial resolution compared with other imaging modalities such as CT and magnetic resonance imaging (MRI), and is considered the most reliable and efficient diagnostic modality for pancreatic diseases. The EUS-based Rosemont classification plays an important role in diagnosing CP in clinical practice. Evaluation of tissue stiffness can be another option to assess the diagnosis and progression of CP, and MRI and EUS can be used to assess CP not only with imaging, but also with elasticity measurement. MR and EUS elastography are expected to provide new alternative diagnostic tools for assessment of fibrosis in CP, which is difficult to evaluate pathologically.
first_indexed 2024-04-11T20:42:17Z
format Article
id doaj.art-1467403e082b4655b8adb22fb2753205
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-04-11T20:42:17Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-1467403e082b4655b8adb22fb27532052022-12-22T04:04:09ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2022-01-011210.3389/fphys.2021.800516800516Imaging of Fibrosis in Chronic PancreatitisYasunobu YamashitaReiko AshidaMasayuki KitanoChronic pancreatitis (CP) describes long-standing inflammation of the pancreas, which leads to irreversible and progressive inflammation of the pancreas with fibrosis. CP also leads to abdominal pain, malnutrition, and permanent impairment of exocrine/endocrine functions. However, it is difficult to assess CP pathologically, and imaging modalities therefore play an important role in the diagnosis and assessment of CP. There are four modalities typically used to assess CP. Pancreatic duct features are assessed with magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP). However, ERCP is a rather invasive diagnostic modality for CP, and can result in adverse events such as post-ERCP pancreatitis. Computed tomography (CT) is often the most appropriate initial imaging modality for patients with suspected CP, and has high diagnostic specificity. However, CT findings typically only appear in advanced stages of CP, and it is difficult to detect early CP. Endoscopic ultrasonography (EUS) provides superior spatial resolution compared with other imaging modalities such as CT and magnetic resonance imaging (MRI), and is considered the most reliable and efficient diagnostic modality for pancreatic diseases. The EUS-based Rosemont classification plays an important role in diagnosing CP in clinical practice. Evaluation of tissue stiffness can be another option to assess the diagnosis and progression of CP, and MRI and EUS can be used to assess CP not only with imaging, but also with elasticity measurement. MR and EUS elastography are expected to provide new alternative diagnostic tools for assessment of fibrosis in CP, which is difficult to evaluate pathologically.https://www.frontiersin.org/articles/10.3389/fphys.2021.800516/fullchronic pancreatitisfibrosiselastographyEUSERCPMRI
spellingShingle Yasunobu Yamashita
Reiko Ashida
Masayuki Kitano
Imaging of Fibrosis in Chronic Pancreatitis
Frontiers in Physiology
chronic pancreatitis
fibrosis
elastography
EUS
ERCP
MRI
title Imaging of Fibrosis in Chronic Pancreatitis
title_full Imaging of Fibrosis in Chronic Pancreatitis
title_fullStr Imaging of Fibrosis in Chronic Pancreatitis
title_full_unstemmed Imaging of Fibrosis in Chronic Pancreatitis
title_short Imaging of Fibrosis in Chronic Pancreatitis
title_sort imaging of fibrosis in chronic pancreatitis
topic chronic pancreatitis
fibrosis
elastography
EUS
ERCP
MRI
url https://www.frontiersin.org/articles/10.3389/fphys.2021.800516/full
work_keys_str_mv AT yasunobuyamashita imagingoffibrosisinchronicpancreatitis
AT reikoashida imagingoffibrosisinchronicpancreatitis
AT masayukikitano imagingoffibrosisinchronicpancreatitis